This project is focused on determining if patient-reported outcomes are better correlated with actual dose delivered than with planned dose in prostate cancer patients receiving radiotherapy.
The project will use daily cone-beam CT images to calculate the daily and total radiation dose delivered to patients, and the Opal app to collect their patient-reported outcomes.